Abstract
INTRODUCTION: Pemphigoid nodularis is identified as a rare clinical variant of bullous pemphigoid (BP), often requiring detailed diagnostic methods due to its atypical presentations, with the concurrent occurrence of psoriasis being rare. CASE PRESENTATION: We report the use of tofacitinib in a 66-year-old female with pemphigoid nodularis combined with psoriasis with significant results. CONCLUSION: Our research suggests that tofacitinib could effectively treat pemphigoid nodularis in the presence of psoriasis, offering convenient administration and promising efficacy compared to traditional therapies.